Schmitt Industries Announces Second Quarter Fiscal 2014

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Schmitt Industries Announces Second Quarter Fiscal 2014 Operating Results

PORTLAND, Ore., Jan. 10, 2014 (GLOBE NEWSWIRE) -- Schmitt Industries, Inc. (Nasdaq: SMIT ) today announced its operating results for the three and six months ended November 30, 2013. For the three months ended November 30, 2013, total sales increased $440,793, or 16.3%, to $3,143,052 from $2,702,259 in the three months ended November 30, 2012. For the six months ended November 30, 2013, total sales decreased $340,425, or 5.3%, to $6,042,499 from $6,382,924 in the six months ended November 30, 2012. Net loss was $163,201, or $0.05 per fully diluted share, for the three months ended November 30, 2013 as compared to $104,604, or $0.03 per fully diluted share, for the three months ended November 30, 2012. Net loss was $309,760, or $0.10 per fully diluted share, for the six months ended November 30, 2013 as compared to net income of $15,544, or $0.01 per fully diluted share, for the six months ended November 30, 2012.

Balancer segment sales increased $104,261, or 5.6%, to $1,965,922 for the three months ended November 30, 2013 compared to $1,861,661 for the three months ended November 30, 2012, primarily due to an increase in sales into Asia and to a lesser extent Europe in the second quarter.

Balancer segment sales decreased $256,946, or 6.2%, to $3,867,738 for the six months ended November 30, 2013 compared to $4,124,684 for the six months ended November 30, 2012. The decrease in worldwide balancer sales for the six month period ended November 30, 2013 is due to lower volumes of shipments into Asia in the first quarter of the current fiscal year compared to the first quarter of the prior year.

Measurement segment sales increased $336,532, or 40.0%, to $1,177,130 for the three months ended November 30, 2013 compared to $840,598 for the three months ended November 30, 2012, driven by an increase in sales of remote tank monitoring products and related services and laser-based light-scatter surface measurement products. Xact® revenues increased $120,521, or 119.8%, to $221,158 during the second quarter of Fiscal 2014 as compared to $100,637 for the same period in the prior year.

Measurement segment sales decreased $83,479, or 3.7%, to $2,174,761 for the six months ended November 30, 2013 compared to $2,258,240 for the six months ended November 30, 2012. The decrease in worldwide measurement system sales for the six month period ended November 30, 2013 is primarily due to lower volumes of shipments of laser-based distance measurement and dimensional sizing products offset by increases in sales of remote tank monitoring products and related services and laser-based light-scatter surface measurement products. Xact® revenues increased $143,576, or 37.0%, to $531,684 during the first half of Fiscal 2014 as compared to $388,108 for the same period in the prior year.

Gross profit for the three months ended November 30, 2013 decreased to 46.7% as compared to 57.1% for the three months ended November 30, 2012. For the six months ended November 30, 2013, gross profit decreased to 46.3% as compared to 53.5% for the six months ended November 30, 2012. These overall decreases in gross profit for both the three and six month periods ended November 30, 2013 as compared to the prior periods are primarily due to shifts in product sales mix involving five product lines and the impact of increased costs associated with the products sold.

"Our results for the second quarter of Fiscal 2014 are showing signs that Asia, and particularly China, is slowly recovering from the slowdown in the manufacturing sector of their economy," commented Jim Fitzhenry, President and CEO of Schmitt Industries. "In addition, we are beginning to see some increased sales of our SBS products into Europe. We are also encouraged by the continued development of our Xact® product line, which posted another increase in revenues as compared to the second quarter of the prior year. We will continue to focus on sales channel and product development and growing our market share in Europe for our SBS product line and in Latin America for our Xact product line," Fitzhenry concluded.

About Schmitt Industries

Schmitt Industries, Inc. (the Company) designs, manufactures and sells high precision test and measurement products for two main business segments: the Balancer Segment and the Measurement Segment. For the Balancer Segment, the Company designs, manufactures and sells computer-controlled vibration detection, balancing and process control systems for the worldwide machine tool industry, particularly for grinding machines. For the Measurement Segment, the Company designs, manufactures and sells laser and white light sensors for distance, dimensional and area measurement for a wide variety of commercial applications, laser-based microroughness measurement products for the semiconductor wafer and hard disk drive industries and for other industrial applications, laser-based surface analysis and measurement products for a variety of scientific applications, and ultrasonic measurement products that accurately measure the liquid levels of propane tanks and transmit that data via satellite to a secure web site for display. The Company also provides sales and service for Europe and parts of Asia through its wholly owned subsidiary, Schmitt Europe Limited (SEL), located in Coventry, England and through its sales representative office located in Shanghai, China.

FORWARD-LOOKING STATEMENTS

Certain statements in this release, including but not limited to remarks by Jim Fitzhenry, are "forward-looking statements." These statements are based upon current expectations, estimates and projections about the Company's business that are based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including, but not limited to, general economic conditions and global financial concerns, the volatility of the Company's primary markets, efforts to accelerate growth in sales of the Xact® tank monitoring systems and the ability to satisfy expected demand, the ability to develop new products to satisfy changes in consumer demands, the intensity of competition, the effect on production time and overall costs of products if any of our primary suppliers are lost or if a primary supplier increases the prices of raw materials or components, the ability to ramp up manufacturing to satisfy increasing demand, maintenance of a significant investment in inventories in anticipation of future sales, existing cash and credit facilities level which may not be sufficient to fund future growth, fluctuations in quarterly and annual operating results, attracting and retaining key management and qualified technical and sales personnel, changes in effective tax rates, the ability to reduce operating costs if sales decline, increased costs due to changes in securities laws and regulations, protection of intellectual property rights, and risks from international sales and currency fluctuations.

For further information regarding risks and uncertainties associated with the Company's business, please refer to Schmitt's SEC filings, including, but not limited to, its Forms 10-K, 10-Q and 8-K.

The forward-looking statements in this release speak only as of the date on which they were made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release, or for changes to this document made by wire services or internet service providers.

     
SCHMITT INDUSTRIES, INC.
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
     
  November 30, 2013 May 31, 2013
ASSETS
Current assets    
Cash and cash equivalents $ 2,115,635  $ 1,909,071
Accounts receivable, net of allowance of $31,663 and $30,576 at November 30, 2013 and May 31, 2013, respectively  2,180,229  1,980,685
Inventories  4,665,685  5,054,087
Prepaid expenses  131,262  219,492
Income taxes receivable  21,609  48,095
   9,114,420  9,211,430
Property and equipment    
Land  299,000  299,000
Buildings and improvements  1,805,951  1,805,951
Furniture, fixtures and equipment  1,313,464  1,312,028
Vehicles  121,835  121,835
   3,540,250  3,538,814
Less accumulated depreciation and amortization  (2,311,911)  (2,203,924)
   1,228,339  1,334,890
Other assets    
Intangible assets, net  1,010,961  1,078,278
TOTAL ASSETS  $ 11,353,720  $ 11,624,598
     
LIABILITIES & STOCKHOLDERS' EQUITY  
Current liabilities  
Accounts payable $ 547,479  $ 918,094
Accrued commissions  203,251  273,307
Accrued payroll liabilities  100,126  131,772
Other accrued liabilities  319,650  286,307
Line of credit  400,000 0
Total current liabilities  1,570,506  1,609,480
Stockholders' equity    
Common stock, no par value, 20,000,000 shares authorized, 2,990,910 shares issued and outstanding at both November 30, 2013 and May 31, 2013  10,394,456  10,369,524
Accumulated other comprehensive loss  (279,000)  (331,924)
Retained earnings  (332,242)  (22,482)
Total stockholders' equity  9,783,214  10,015,118
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY  $ 11,353,720  $ 11,624,598
     
         
SCHMITT INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND SIX MONTHS ENDED NOVEMBER 30, 2013 AND 2012
(UNAUDITED)
         
  Three Months Ended November 30, Six Months Ended November 30,
  2013 2012 2013 2012
         
Net sales  $ 3,143,052  $ 2,702,259  $ 6,042,499  $ 6,382,924
Cost of sales  1,675,184  1,160,031  3,243,509  2,966,748
Gross profit  1,467,868  1,542,228  2,798,990  3,416,176
         
Operating expenses:        
General, administration and sales  1,507,046  1,523,918  2,858,748  3,156,733
Research and development  112,096  131,365  238,860  246,674
Total operating expenses  1,619,142  1,655,283  3,097,608  3,403,407
         
Operating income (loss)  (151,274)  (113,055)  (298,618)  12,769
         
Other income (expense)  (9,546)  7,915  (6,093)  8,427
         
Income (loss) before income taxes  (160,820)  (105,140)  (304,711)  21,196
         
Provision (benefit) for income taxes  2,381  (536)  5,049  5,652
         
Net income (loss)  $ (163,201)  $ (104,604)  $ (309,760)  $ 15,544
         
Net earnings (loss) per common share:      
         
Basic  $ (0.05)  $ (0.03) $ (0.10) $ 0.01
         
Weighted average number of common shares, basic  2,990,910  2,990,910  2,990,910  2,990,910
         
Diluted $ (0.05)  $ (0.03) $ (0.10) $ 0.01
         
Weighted average number of common shares, diluted  2,990,910  2,990,910  2,990,910  3,003,828
         

For more information contact: Ann M Ferguson, CFO and Treasurer (503) 227-7908 or visit our web site at www.schmitt-ind.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 337

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 288

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 97

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 117

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 206

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover the Enhanced Features of the New ONYX RX32 Scrubber

Updated Category News Views 116

Introducing the New RX32 Ride-On Floor Scrubber Optimal Performance for Large-Area Cleaning In response to the growing need for effective cleaning solutions, ONYX Systems, LLC launches the advanced RX32 Ride-On Floor Scrubber. This 32-inch scrubber is designed specifically to enhance cleaning efficiency and productivity in large facilities. Unmatched Cleaning Power The...

Continue Reading
Deckers Outdoor Achieves Record Stock Price Amid Growth

Updated Category News Views 253

Deckers Outdoor Corporation Reaches New Stock Milestone Deckers Outdoor Corporation (NYSE: DECK), known for its exceptional footwear and apparel offerings, has achieved a remarkable milestone as its stock price climbs to an all-time high of $213.03. This impressive rise is indicative of the company's strong financial health and robust market performance. With a...

Continue Reading
Remarkable Growth in Badger Meter's Financial Performance

Updated Category News Views 76

Badger Meter's Impressive Q3 2024 Financial Results Badger Meter, Inc. (NYSE: BMI) has recently reported its remarkable financial outcomes for the third quarter that ended on September 30, 2024. The company has recorded impressive growth across its various financial metrics, indicating strong market demand and operational excellence. Key Highlights of Q3 2024 The latest...

Continue Reading
Perion Network's Collaboration with Experian Boosts Ad Targeting

Updated Category News Views 242

Perion Network Partners with Experian to Enhance Ad Solutions Perion Network (NASDAQ: PERI), a leading figure in the digital advertising technology sector, is taking a significant step forward with its collaboration with Experian, a renowned global data and analytics company. This strategic partnership aims to enhance Perion's advertising capabilities, focusing on...

Continue Reading
Novo Nordisk Investors Seek Class Action Guidance Following Lawsuit

Updated Category News Views 213

Insights into the Novo Nordisk Class Action Lawsuit Recent news has surfaced regarding Novo Nordisk A/S (NYSE: NVO), a major player in the global pharmaceutical industry, which is making headlines following the announcement of a class action lawsuit. This legal action is spearheaded by Berger Montague, a notable law firm based in various cities across the United States,...

Continue Reading